These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31574195)

  • 61. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Construction of a Recombinant Lactococcus lactis Strain Expressing a Variant Porcine Epidemic Diarrhea Virus S1 Gene and Its Immunogenicity Analysis in Mice.
    Guo M; Yi S; Guo Y; Zhang S; Niu J; Wang K; Hu G
    Viral Immunol; 2019 Apr; 32(3):144-150. PubMed ID: 30855219
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Deletion of a decoy epitope in porcine circovirus 2 (PCV2) capsid protein affects the protective immune response in mice.
    Kim K; Shin M; Hahn TW
    Arch Virol; 2020 Dec; 165(12):2829-2835. PubMed ID: 33000310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Porcine reproductive and respiratory syndrome virus as a vector: immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs.
    Pei Y; Hodgins DC; Wu J; Welch SK; Calvert JG; Li G; Du Y; Song C; Yoo D
    Virology; 2009 Jun; 389(1-2):91-9. PubMed ID: 19423145
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus.
    Liu LJ; Suzuki T; Tsunemitsu H; Kataoka M; Ngata N; Takeda N; Wakita T; Miyamura T; Li TC
    Arch Virol; 2008; 153(12):2291-5. PubMed ID: 18998045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protective efficacy of a DNA vaccine encoding capsid protein of porcine circovirus-like virus P1 against porcine circovirus 2 in mice.
    Zhang D; He K; Wen L; Fan H
    Microbiol Immunol; 2018 Mar; 62(3):195-199. PubMed ID: 29315776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV.
    Nawagitgul P; Harms PA; Morozov I; Thacker BJ; Sorden SD; Lekcharoensuk C; Paul PS
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):33-40. PubMed ID: 11777826
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel vaccine against Porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection.
    Lin HX; Ma Z; Yang XQ; Fan HJ; Lu CP
    Vet Microbiol; 2014 Jun; 171(1-2):198-205. PubMed ID: 24726504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selection and identification of single-domain antibody fragment against capsid protein of porcine circovirus type 2 (PCV2) from C. bactrianus.
    Yang S; Shang Y; Yin S; Tian H; Chen Y; Sun S; Jin Y; Liu X
    Vet Immunol Immunopathol; 2014 Jul; 160(1-2):12-9. PubMed ID: 24736187
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus-like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative.
    Aguilera BE; Chávez-Calvillo G; Elizondo-Quiroga D; Jimenez-García MN; Carrillo-Tripp M; Silva-Rosales L; Hernández-Gutiérrez R; Gutiérrez-Ortega A
    Biotechnol Appl Biochem; 2017 May; 64(3):406-414. PubMed ID: 26970530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
    Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
    Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oral Immunization with
    Li F; Wang X; Ma R; Wu W; Teng F; Cheng X; Jiang Y; Zhou H; Wang L; Tang L; Qiao X; Li Y
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372508
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Attenuated Streptococcus equi ssp. zooepidemicus as a bacterial vector for expression of porcine circovirus type 2 capsid protein.
    Wei Z; Fu Q; Liu X; Chen Y
    FEMS Microbiol Lett; 2012 Jul; 332(1):20-6. PubMed ID: 22489773
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhanced protective immune response to PCV2 adenovirus vaccine by fusion expression of Cap protein with InvC in pigs.
    Zhang Z; Luo Y; Zhang Y; Guo K
    J Vet Sci; 2019 Jul; 20(4):e35. PubMed ID: 31364320
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice.
    Shen HG; Zhou JY; Huang ZY; Guo JQ; Xing G; He JL; Yan Y; Gong LY
    J Gen Virol; 2008 Aug; 89(Pt 8):1857-1865. PubMed ID: 18632956
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.
    Pérez-Martín E; Gómez-Sebastián S; Argilaguet JM; Sibila M; Fort M; Nofrarías M; Kurtz S; Escribano JM; Segalés J; Rodríguez F
    Vaccine; 2010 Mar; 28(11):2340-9. PubMed ID: 20056179
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice.
    Liu X; Ouyang T; Ma T; Ouyang H; Pang D; Ren L
    BMC Vet Res; 2018 Apr; 14(1):137. PubMed ID: 29685143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.